Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

This study aims to evaluate serum beta-2 microglobulin (β2M) as a diagnostic biomarker for acute primary Epstein: Barr virus (EBV) infection in children, Additionally, serum vitamin D3 levels were compared between EBV-infected children and children with viral upper respiratory tract infection to explore their potential clinical relevance.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

This study used a retrospective cross-sectional design.

Source: Methods.

The study included children aged 0 to 18 years, consistent with the standard definition of the pediatric age group.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Serum beta-2 microglobulin as a diagnostic biomarker for pediatric Epstein-Barr virus infections: a retrospective study

Cross-sectional study · Frontiers in Pediatrics · 2026

Original publication title

Serum beta-2 microglobulin as a diagnostic biomarker for pediatric Epstein: Barr virus infections: a retrospective study

Sheng Cheng; Jingjing Pan; Bing Wang; Xulong Cai; Tongjin Yin

© 2026 Cheng, Pan, Wang, Cai and Yin.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

The serum β2M levels are significantly increased in the stage of primary EBV infection in children, and β2M appears to be a promising biomarker for predicting primary EBV infection. The serum vitamin D3 levels are significantly reduced in children with primary EBV infection, and the protective effect of vitamin D supplementation in those children warrants additional clinical exploration.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

This study aims to evaluate serum beta-2 microglobulin (β2M) as a diagnostic biomarker for acute primary Epstein: Barr virus (EBV) infection in children, Additionally, serum vitamin D3 levels were compared between EBV-infected children and children with viral upper respiratory tract infection to explore their potential clinical relevance.

Source: Objective

Abstract: What methods does the paper describe?

A total of 129 children with acute primary EBV infection were identified as the EBV group, while 130 children with viral upper respiratory tract infections in the same age group hospitalized during the same period were identified as the control group. The age, gender, and laboratory indicators of the two groups were analyzed and compared. Pearson's correlation was used to analyze the correlation between β2M and serum EBV-DNA concentration. The receiver operating characteristic (ROC) curve was drawn, and the threshold and area under the curve (AUC) of β2M for predicting the diagnosis of EBV infection were calculated.

Source: Methods

Abstract: Results

The white blood cell count, serum lactate dehydrogenase, and alanine aminotransferase levels in the EBV group were significantly than those in the control group (P < 0.0001), and Serum β2M level were significantly higher in the EBV group than in the control group (P < 0.001), while serum vitamin D3 levels were significantly lower (P < 0.001). Pearson's correlation analysis showed a positive correlation between serum β2M levels and serum EBV-DNA load (r = 0.469, P < 0.01).

ROC curve analysis revealed that the AUC of serum β2M for diagnosing EBV infection was 0.907 (95% confidence interval 0.8723 to 0.9412; P < 0.01), with an optimal threshold of 3.3 mg/L, a specificity of 62.1%, and a sensitivity of 90.8%.

Source: Results

Abstract: Conclusion

The serum β2M levels are significantly increased in the stage of primary EBV infection in children, and β2M appears to be a promising biomarker for predicting primary EBV infection. The serum vitamin D3 levels are significantly reduced in children with primary EBV infection, and the protective effect of vitamin D supplementation in those children warrants additional clinical exploration.

Source: Conclusion
Authors’ abstract

Objective

This study aims to evaluate serum beta-2 microglobulin (β2M) as a diagnostic biomarker for acute primary Epstein: Barr virus (EBV) infection in children, Additionally, serum vitamin D3 levels were compared between EBV-infected children and children with viral upper respiratory tract infection to explore their potential clinical relevance.

Methods

A total of 129 children with acute primary EBV infection were identified as the EBV group, while 130 children with viral upper respiratory tract infections in the same age group hospitalized during the same period were identified as the control group. The age, gender, and laboratory indicators of the two groups were analyzed and compared. Pearson's correlation was used to analyze the correlation between β2M and serum EBV-DNA concentration. The receiver operating characteristic (ROC) curve was drawn, and the threshold and area under the curve (AUC) of β2M for predicting the diagnosis of EBV infection were calculated.

Results

The white blood cell count, serum lactate dehydrogenase, and alanine aminotransferase levels in the EBV group were significantly than those in the control group (P < 0.0001), and Serum β2M level were significantly higher in the EBV group than in the control group (P < 0.001), while serum vitamin D3 levels were significantly lower (P < 0.001). Pearson's correlation analysis showed a positive correlation between serum β2M levels and serum EBV-DNA load (r = 0.469, P < 0.01).

ROC curve analysis revealed that the AUC of serum β2M for diagnosing EBV infection was 0.907 (95% confidence interval 0.8723 to 0.9412; P < 0.01), with an optimal threshold of 3.3 mg/L, a specificity of 62.1%, and a sensitivity of 90.8%.

Conclusion

The serum β2M levels are significantly increased in the stage of primary EBV infection in children, and β2M appears to be a promising biomarker for predicting primary EBV infection. The serum vitamin D3 levels are significantly reduced in children with primary EBV infection, and the protective effect of vitamin D supplementation in those children warrants additional clinical exploration.

Publication and source details

Original title: Serum beta-2 microglobulin as a diagnostic biomarker for pediatric Epstein: Barr virus infections: a retrospective study

Sheng Cheng; Jingjing Pan; Bing Wang; Xulong Cai; Tongjin Yin

Frontiers in Pediatrics · 2026

* Correspondence: Tongjin Yin yxj3313@ntu.edu.cn© 2026 Cheng, Pan, Wang, Cai and Yin.2026Cheng, Pan, Wang, Cai and Yinhttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was received for this work and/or its publication. This work was supported by the Yancheng Key Research and Development Program (Social Development) (Grant No. YCBE202226); and the 2021 Scientific Research Project of Clinical College, Jiangsu Medical Vocational College (Grant No. 20219133).

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T22:12:57.355179+00:00

DOI: 10.3389/fped.2026.1853250 · PMC13365129